Literature DB >> 3873343

Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.

C F Saller, A I Salama.   

Abstract

SKF 38393, a selective D-1 dopamine (DA) agonist, enhanced the ability of spiperone, a D-2 antagonist, to increase rat striatal DA metabolite concentrations. Conversely, SKF 38393 reduced the abilities of pergolide and LY 171555, D-2 agonists, to decrease striatal DA metabolite concentrations. These findings are discussed in terms of a possible functional interaction between D-1 and D-2 DA receptors.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3873343     DOI： 10.1016/0014-2999(85)90435-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


  12 in total

1.  Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming.

Authors:  S A Parashos; C Marin; P Barone; V Kapitzoglou-Logothetis; T N Chase
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro.

Authors:  A J Azzaro; J Liccione; J Lucci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  Age-related changes in human D1 dopamine receptors measured by positron emission tomography.

Authors:  T Suhara; H Fukuda; O Inoue; T Itoh; K Suzuki; T Yamasaki; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.

Authors:  A M Zarkovsky; K S Cereska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

5.  Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.

Authors:  G Fabbrini; A Braun; M M Mouradian; C A Tamminga; T N Chase
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.

Authors:  J L Nunes; N A Sharif; A D Michel; R L Whiting
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

7.  Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.

Authors:  A Guyon; F Assouly-Besse; G Biala; A J Puech; M H Thiébot
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.

Authors:  H Rollema; M G Feenstra; C J Grol; M H Lewis; L Staples; R B Mailman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

9.  Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.

Authors:  J D Winkler; K Thermos; B Weiss
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.

Authors:  O Magnusson; B Mohringe; C J Fowler
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.